Maintenance for the week of December 16:
• PC/Mac: No maintenance – December 16
• NA megaservers for patch maintenance – December 17, 4:00AM EST (9:00 UTC) - 12:00PM EST (17:00 UTC)
• EU megaservers for patch maintenance – December 17, 9:00 UTC (4:00AM EST) - 17:00 UTC (12:00PM EST)

MagDK situation on PTS 27

FalZhardumDin
FalZhardumDin
✭✭
What do you guys think about MagDK after reading the patch notes? Right now I main it and it feels very strong in regards of DPS and sustain. But after nerfs to Blood for Blood, PFGD and Thrassian Stranglers I am worried it won't be viable anymore. I really love the playstyle and the possibility to use other sets like Z'en or Martial Knowledge. It opened a lot of fun and satisfactory trial setups for end game players. Do you have any comments on it? I am really confused and a little nervous about the future of this class... and how ZOS treats it.
  • robpr
    robpr
    ✭✭✭✭✭
    My PTS is still downloading, but Asylum getting back to every 2 cast I might be considering using it again.
    What I currently have on aim is the potential uptime of Acuity and Master Architect that scales of ult spent. If Acuity will happen to be trash, I'll probably use Elfbane and MA.
  • MrBrownstone
    MrBrownstone
    ✭✭✭✭✭
    Since when these 3 sets have any exclusive benefits for MagDK? They're sets used by all Magicka classes so the class will be in the same spot compared to others.
  • FalZhardumDin
    FalZhardumDin
    ✭✭
    Since when these 3 sets have any exclusive benefits for MagDK? They're sets used by all Magicka classes so the class will be in the same spot compared to others.

    It's sort of has exclusive benefits. If you look into high score ESO logs compositions the sets I mentioned do very well on MagDK. Currently the optimal way of playing magdk is as support damage dealer if you are pushing for scores or triple veteran hard mode challenges. It opens other sets to go well with the group (like the new Opportunists for example) and maximize damage with buffs/debuffs.
Sign In or Register to comment.